Alzheimer's disease is aetiologically heterogeneous, but the pathogenesis is often considered to be initiated by the deposition of amyloid fibrils, followed by neuritic tau pathology and neuronal death. A variety of inflammatory proteins has been identified in the brains of patients with Alzheimer's disease post mortem. In this article, Piet Eikelenboom and colleagues review evidence to suggest that the inflammatory processes are intimately involved in several crucial events in the pathological cascade. This suggests possibilities for the treatment of Alzheimer's disease with anti-inflammatory drugs
Neuropathological studies have revealed the presence of a broad variety of inflammation-related prot...
The idea that an inflammatory process is involved in Alzheimer's disease (AD) was proposed already h...
Neuroinflammation is a constant event in Alzheimer’s disease (AD), but the current knowledge is insu...
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Most AD patients develop the di...
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Most AD patients develop the di...
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Most AD patients develop the di...
The interest of scientists in the involvement of inflammation-related mechanisms in the pathogenesis...
Aging population brings an ever-increasing global burden of dementia, and Alzheimer's disease (AD) i...
Considerable evidence gained over the past decade has supported the conclusion that neuroinflammatio...
Evidence for the involvement of inflammatory processes in the pathogenesis of Alzheimer's disease (A...
A significant increase in inflammation has been shown to be a crucial factor in the progression of t...
Alzheimer's disease (AD) is a neurodegenerative condition characterized by the formation of amyloid-...
Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease which in Weste...
Alzheimer’s disease is a progressive neurodegenerative disorder, affecting millions of people worldw...
Most neurodegenerative disorders are characterised by an inflammatory process in the brain. Alzheime...
Neuropathological studies have revealed the presence of a broad variety of inflammation-related prot...
The idea that an inflammatory process is involved in Alzheimer's disease (AD) was proposed already h...
Neuroinflammation is a constant event in Alzheimer’s disease (AD), but the current knowledge is insu...
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Most AD patients develop the di...
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Most AD patients develop the di...
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Most AD patients develop the di...
The interest of scientists in the involvement of inflammation-related mechanisms in the pathogenesis...
Aging population brings an ever-increasing global burden of dementia, and Alzheimer's disease (AD) i...
Considerable evidence gained over the past decade has supported the conclusion that neuroinflammatio...
Evidence for the involvement of inflammatory processes in the pathogenesis of Alzheimer's disease (A...
A significant increase in inflammation has been shown to be a crucial factor in the progression of t...
Alzheimer's disease (AD) is a neurodegenerative condition characterized by the formation of amyloid-...
Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease which in Weste...
Alzheimer’s disease is a progressive neurodegenerative disorder, affecting millions of people worldw...
Most neurodegenerative disorders are characterised by an inflammatory process in the brain. Alzheime...
Neuropathological studies have revealed the presence of a broad variety of inflammation-related prot...
The idea that an inflammatory process is involved in Alzheimer's disease (AD) was proposed already h...
Neuroinflammation is a constant event in Alzheimer’s disease (AD), but the current knowledge is insu...